India in Pharma sector:
- India enjoys an important position in the global pharmaceuticals sector, as India is the largest provider of generic drugs globally.
- The Indian pharmaceutical industry meets over 50% of global demand for various vaccines, 40% of generic demand in the U.S. and 25% of all medicine in the U.K.
- Presently, over 80% of the antiretroviral drugs used globally to combat AIDS (Acquired Immune Deficiency Syndrome) are supplied by Indian pharmaceutical firms.
- The Indian pharmaceuticals market is the world’s third-largest in terms of volume and thirteenth-largest in terms of value. It has established itself as a global manufacturing and research hub.
Context:
- US President Donald Trump has said he has urged Prime Minister Narendra Modi to relax India’s ban on hydroxychloroquine tablets so that the drug can be used to treat America’s COVID-19 patients.
- India is one of the global leaders in the production of the drug.
Hydroxy-chloroquine against COVID-19:
- The drug shows antiviral activity in vitro against coronaviruses, and specifically, SARS-CoV-2 [the virus that causes COVID-19].
- Further, the study suggests that prophylaxis (treatment given to prevent disease) with hydroxy-chloroquine at approved doses could prevent SARS-CoV-2 infection and may help to improve viral shedding.
- Clinical trials are under way in China to know whether the drug can be used for treatment.
About Hydroxy-chloroquine :
- Hydroxy-chloroquine is an oral drug used in the treatment of autoimmune diseases such as rheumatoid arthritis. Autoimmune diseases are in which the body’s immune system attacks healthy cells.
- The popular anti-parasitic medication has been available since the 1940s. It’s been used to treat malaria.
- HCQ is a derivative of chloroquine, and has fewer side-effects.
- Rheumatoid arthritis is a chronic inflammatory disorder affecting many joints, including those in the hands and feet.
- Chloroquine works by increasing the levels of haem or heme, a substance toxic to the malarial parasite in the blood. This kills the parasite and stops the infection from spreading.
ICMR Recommends Use of Hydroxy-Chloroquine:
- Indian Council of Medical Research (ICMR) is the apex body in India for the formulation, coordination and promotion of biomedical research.
- Its mandate is to conduct, coordinate and implement medical research for the benefit of the Society, translating medical innovations into products/processes and introducing them into the public health system.
- The Indian Council of Medical Research (ICMR) recommends the use of hydroxychloroquine as a prophylactic for asymptomatic healthcare workers and contacts of people who have been infected by the virus.
- The ICMR’s decision on wider use of the drug will, reportedly, depend on further research.
Conclusion:
- India has one of the lowest manufacturing costs in the world – lower than that of the U.S. and almost half of the cost in Europe.
- India should look up to and invest in biotechnology. India’s biotechnology industry, comprising biopharmaceuticals, bio-services, bio agriculture, bio-industry and bioinformatics is expected to grow at an average rate of around 30% a year and reach $100 billion by 2025.
- To ensure health security of Indian people, revival of R&D and public sector API manufacturers is necessary. For example, the Council of Scientific and Industrial Research (CSIR) should be promoted to invest in R&D.
Comments
Post a Comment